athenahealth (NASDAQ:ATHN) issued its quarterly earnings data on Friday. The health services provider reported $0.81 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.10, Morningstar.com reports. athenahealth had a net margin of 8.71% and a return on equity of 14.71%. The firm had revenue of $331.40 million for the quarter, compared to analysts’ expectations of $336.98 million. During the same quarter in the prior year, the business earned $0.56 EPS. The business’s quarterly revenue was up 8.8% on a year-over-year basis. athenahealth updated its FY 2018 guidance to EPS.
ATHN traded down $4.53 during trading on Friday, reaching $120.35. 849,908 shares of the company traded hands, compared to its average volume of 557,273. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.62 and a quick ratio of 2.62. athenahealth has a 12-month low of $116.77 and a 12-month high of $163.94. The firm has a market cap of $5.12 billion, a P/E ratio of 76.66, a price-to-earnings-growth ratio of 2.23 and a beta of 0.80.
In other athenahealth news, insider Daniel P. Haley sold 2,204 shares of the stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $127.23, for a total transaction of $280,414.92. Following the completion of the sale, the insider now directly owns 10,555 shares of the company’s stock, valued at approximately $1,342,912.65. The sale was disclosed in a legal filing with the SEC, which is available at this link. Over the last ninety days, insiders have sold 2,654 shares of company stock valued at $340,770. Insiders own 2.90% of the company’s stock.
Several research firms recently issued reports on ATHN. Leerink Swann set a $138.00 target price on shares of athenahealth and gave the stock a “hold” rating in a report on Thursday, November 1st. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, October 13th. Royal Bank of Canada reissued a “hold” rating and issued a $140.00 target price on shares of athenahealth in a report on Friday, September 28th. MED reduced their target price on shares of athenahealth to $140.00 and set a “hold” rating for the company in a report on Wednesday, September 19th. Finally, SunTrust Banks reduced their target price on shares of athenahealth to $150.00 in a report on Wednesday, September 19th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $153.79.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.com-unik.info/2018/11/10/athenahealth-athn-posts-quarterly-earnings-results-beats-estimates-by-0-10-eps.html.
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Read More: How a Put Option Works
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.